FDA pulls authorization for AstraZeneca’s Covid antibody drug Evusheld

fda-pulls-authorization-for-astrazeneca’s-covid-antibody-drug-evusheld

The FDA withdrew the emergency use authorization for AstraZeneca’s Covid antibody cocktail Evusheld because it does not work against omicron subvariant XBB.1.5

0 Shares:
You May Also Like